Myung In Pharmaceutical LTD. (KRX:317450)

KRX:317450 Statistics

Total Valuation

KRX:317450 has a market cap or net worth of KRW 1.15 trillion. The enterprise value is 871.79 billion.

Market Cap	1.15T
Enterprise Value	871.79B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KRX:317450 has 14.60 million shares outstanding.

Current Share Class	14.60M
Shares Outstanding	14.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	70.38%
Owned by Institutions (%)	3.42%
Float	4.32M

Valuation Ratios

The trailing PE ratio is 11.30.

PE Ratio	11.30
Forward PE	n/a
PS Ratio	4.09
PB Ratio	2.05
P/TBV Ratio	2.06
P/FCF Ratio	15.29
P/OCF Ratio	12.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.34, with an EV/FCF ratio of 11.61.

EV / Earnings	11.19
EV / Sales	3.11
EV / EBITDA	8.34
EV / EBIT	9.48
EV / FCF	11.61

Financial Position

The company has a current ratio of 8.63, with a Debt / Equity ratio of 0.00.

Current Ratio	8.63
Quick Ratio	7.33
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.03
Interest Coverage	320.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	16.32%
Revenue Per Employee	837.66M
Profits Per Employee	232.58M
Employee Count	335
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, KRX:317450 has paid 20.63 billion in taxes.

Income Tax	20.63B
Effective Tax Rate	20.94%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	19.84
Average Volume (20 Days)	950,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:317450 had revenue of KRW 280.62 billion and earned 77.92 billion in profits. Earnings per share was 6,956.75.

Revenue	280.62B
Gross Profit	170.32B
Operating Income	91.96B
Pretax Income	98.55B
Net Income	77.92B
EBITDA	104.55B
EBIT	91.96B
Earnings Per Share (EPS)	6,956.75

Balance Sheet

The company has 277.87 billion in cash and 2.10 billion in debt, giving a net cash position of 275.77 billion or 18,888.22 per share.

Cash & Cash Equivalents	277.87B
Total Debt	2.10B
Net Cash	275.77B
Net Cash Per Share	18,888.22
Equity (Book Value)	560.58B
Book Value Per Share	50,051.57
Working Capital	358.39B

Cash Flow

In the last 12 months, operating cash flow was 92.76 billion and capital expenditures -17.69 billion, giving a free cash flow of 75.07 billion.

Operating Cash Flow	92.76B
Capital Expenditures	-17.69B
Free Cash Flow	75.07B
FCF Per Share	5,141.95

Margins

Gross margin is 60.69%, with operating and profit margins of 32.77% and 27.77%.

Gross Margin	60.69%
Operating Margin	32.77%
Pretax Margin	35.12%
Profit Margin	27.77%
EBITDA Margin	37.26%
EBIT Margin	32.77%
FCF Margin	26.75%

Dividends & Yields

KRX:317450 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	14.37%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	6.79%
FCF Yield	6.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:317450 has an Altman Z-Score of 2.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.95
Piotroski F-Score	4